Staging and Grading Periodontitis

October 12th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Categories:   Coding   Dental  

We now understand periodontitis may present itself as a manifestation of systemic diseases in fact; according to DeltaDental, research shows that more than 90 percent of all systemic diseases have oral manifestations, including swollen gums, mouth ulcers, dry mouth, and excessive gum problems. Some of these diseases include:

  • Diabetes
  • Leukemia
  • Oral cancer
  • Pancreatic cancer
  • Heart disease
  • Kidney disease

Baby boomers are especially vulnerable to developing diabetes, osteoporosis, and heart disease, the risks of which increase with age. Researchers believe that symptoms of these conditions can manifest in the mouth, making dentists key in diagnosing the diseases. For example:

  • Bad breath and bleeding gums could be indicators of diabetes.
  • Dental x-rays can show the first stages of bone loss.
  • A sore and painful jaw could foreshadow an oncoming heart attack.

Continued research and findings supporting the association between periodontal disease and systemic disease assists with advancement toward improving outcomes and lowering risk factors.

In 1999 periodontitis was represented as a disease entity as either chronic or aggressive according to the ADA, however, this left out important biologic features to distinctly identify between the two and have since been regrouped simply as "periodontitis". We now classify based on staging the full mouth instead of severity alone.  In addition, we use grading to incorporate history, progression, and use risk factors as a way to determine the impact of a patient's general overall health. 

Staging Periodontitis

The following information on staging is available from the American Academy of Periodontology;

Stage I periodontitis (mild disease) patients will have probing depths ≤4 mm, CAL ≤1-2 mm, horizontal bone loss, and will require non-surgical treatment. No post-treatment tooth loss is expected, indicating the case has a good prognosis going into maintenance.

Stage II periodontitis (moderate disease) patients will have probing depths ≤5 mm, CAL ≤3-4 mm, horizontal bone loss, and will require non-surgical and surgical treatment. No post-treatment tooth loss is expected, indicating the case has a good prognosis going into maintenance.

Stage III periodontitis (severe disease) patients will have probing depths ≥6 mm, CAL ≥5 mm, and may have vertical bone loss and/or furcation involvement of Class II or III. This will require surgical and possibly regenerative treatments. There is the potential for tooth loss from 0 to 4 teeth. The complexity of the implant and/or restorative treatment is increased. The patient may require multi-specialty treatment. The overall case has a fair prognosis going into maintenance.

Stage IV periodontitis (very severe disease) patients will have probing depths ≥6 mm, CAL ≥5 mm, and may have vertical bone loss and/or furcation involvement of Class II or III. Fewer than 20 teeth may be present and there is the potential for tooth loss of 5 or more teeth. Advanced surgical treatment and/or regenerative therapy may be required, including augmentation treatment to facilitate implant therapy. Very complex implant and/or restorative treatment may be needed. The patient will often require multi-specialty treatment. The overall case has a questionable prognosis going into maintenance.

Factors Considered

  • CAL -interdental clinical attachment loss
  • Tooth Loss
  • Stage I and II - probing depths
  • Radiographic bone loss
  • Stage III and IV- furcation involvement, ridge defects, and bite collapse 

Other Considerations for Staging Periodontitis 

  • Staging pertains to the whole mouth and is relative to the area with the highest severity and most complex portion of the mouth.
  • Staging is based on the amount of damage that the disease has already progressed to. 
  • Tooth Loss or planned extractions due to Periodontitis is included as a part of active periodontal therapy. 
  • Each complexity moves the staging to the next higher stage.
  • Once a patient is clinically stable they are considered as having periodontal stability, the staging may develop to a higher stage, but not generally to a lower stage.

    NOTE:   According to the American Academy of Periodontology (AAP), "there is one exception to this rule. For instance, if the case was classified as Stage III due to the presence of a vertical defect ≥3 mm or Class II furcation involvement and those sites were successfully regenerated such that the CAL throughout the dentition is now 3-4 mm, the furcation involvement is a Class I or not clinically detectable, and probing depths are ≤5 mm, the stage could change from Stage III to Stage II."

Periodontitis Staging Table











≤4 mm

≤5 mm

≥6 mm

≥6 mm


≤1-2 mm

≤3-4 mm

≥5 mm

≥5 mm


Coronal third(<15%)

Coronal third(15-33%)

Extends beyond 33% or root

Extends beyond 33% of root







No Tooth Loss

No Tooth Loss

≤4 teeth

≥5 teeth


  • Non-surgical
  • Non-surgical
  • Surgical
  • Surgical
  • Possible regenerative
  • Possible multi-specialty care
  • Advanced surgical
  • Possible regenerative
  • Possible augmentation
  • Complex implant and/or restorative
  • Often multi-specialty care






Grading Periodontitis

The grading system helps us determine further progression and helps to identify at what rate the disease may progress. Grading also plays an important part in determining the anticipated response to treatment as well as the potential impact progression may have on their overall health.  Grading uses indicators of the disease and considers damage from any previous active disease. For example, is the patient a smoker or have diabetes? These are risk factors that will help determine the progression of the disease. There is also direct and indirect evidence of progression which is considered in grading such as the % of bone loss and the patient's age.   

Periodontitis Grading Table

Grade A:


Grade B:


Grade C:



No loss over 5 years

< 2 mm over 5 years

≥ 2 mm over 5 years


< 0.25

0.25 to 1.0

> 1.0


Low levels of destruction with biofilm deposits

Moderate levels of destruction with biofilm deposits

Excessive levels of destruction from biofilm deposits; clinical patterns denote rapid progression and/or early-onset disease



< 10 cigarettes/day

≥10 cigarettes/day


Normoglycemic/no diagnosis of diabetes

HbA1c < 7.0% in patients with diabetes

HbA1c ≥ 7.0% in patients with diabetes

Using both Staging and Grading for the Complete Picture

A patient may be in remission and considered a grade "A", which is an indication of low progression, or a slow rate but also have a stage III indicating previous damage.  Using both the staging and the grading gives a more complete assessment of the patient's risk and the expected progression, using an evidenced-based plan for treatment. 

We can see where a diabetic patient with HbA1c of 8.0% (grade C is HbA1c>7.0%) may be a Stage II but has a Grade C periodontitis.  Therefore, the diagnosis would be Stage II Grade C Periodontitis.


Questions, comments?

If you have questions or comments about this article please contact us.  Comments that provide additional related information may be added here by our Editors.

Latest articles:  (any category)

COVID Vaccine Coding Changes as of November 1, 2023
October 26th, 2023 - Wyn Staheli
COVID vaccine changes due to the end of the PHE as of November 1, 2023 are addressed in this article.
Medicare Guidance Changes for E/M Services
October 11th, 2023 - Wyn Staheli
2023 brought quite a few changes to Evaluation and management (E/M) services. The significant revisions as noted in the CPT codebook were welcome changes to bring other E/M services more in line with the changes that took place with Office or Other Outpatient Services a few years ago. As part of CMS’ Medicare Learning Network, the “Evaluation and Management Services Guide” publication was finally updated as of August 2023 to include the changes that took place in 2023. If you take a look at the new publication (see references below),....
Can We Score Interpretation of an EKG Towards E/M Medical Decision Making?
October 10th, 2023 - Aimee Wilcox
When EKGs are performed in the facility setting or even in the physician's office, what are the requirements for reporting the service and who gets credit for scoring data points for Evaluation and Management (E/M) medical decision making (MDM)? Let's take a look at a few coding scenarios related to EKG services to get a better understanding of why this can be problematic.
Accurately Reporting Signs and Symptoms with ICD-10-CM Codes
October 5th, 2023 - Aimee Wilcox
Coders often find themselves unsure of when to report a sign or symptom code documented in the medical record. Some coders find their organization has an EHR that requires a working diagnosis, which is usually a sign or symptom, be entered to order a test or diagnostic study or image. Understanding the guidelines surrounding when signs and symptoms should be reported is the first step in correct coding so let's take a look at some scenarios.
The 2024 ICD-10-CM Updates Include New Codes for Reporting Metabolic Disorders and Insulin Resistance
September 19th, 2023 - Aimee Wilcox
Diabetes is a chronic disease that just seems to consistently be increasing instead of improving resulting in a constant endeavor by medical researchers to identify causal effects and possible treatments. One underlying or precipitating condition that scientists have identified as a precipitating factor in the development of diabetes is insulin resistance, which is a known metabolic disorder. As data becomes available through claims reporting, additional code options become possible with ICD-10-CM.
Documenting and Reporting Postoperative Visits
September 12th, 2023 - Aimee Wilcox
Sometimes we receive questions regarding documentation requirements for specific codes or coding requirements and we respond with information and resources to support our answers. The following question was recently submitted: Are providers required to report postoperative services on claims using 99024, especially if there is no payment for that service? What documentation is required if you are reporting an unrelated Evaluation and Management (E/M) service by the same physician during the postoperative period? 
Understanding Gastroesophageal Reflux Disease and ICD-10-CM Coding
August 22nd, 2023 - Aimee Wilcox
Gastroesophageal reflux disease or GERD for short, is a disease that impacts millions of Americans on a weekly basis. Symptoms are uncomfortable, as are some of the tests used to diagnose it, but understanding the disease, tests, and treatments helps us better understand how to code the disease using ICD-10-CM codes.

Home About Terms Privacy

innoviHealth® - 62 E 300 North, Spanish Fork, UT 84660 - Phone 801-770-4203 (9-5 Mountain)

Copyright © 2000-2023 innoviHealth Systems®, Inc. - CPT® copyright American Medical Association